In another blow to big pharma, India's Supreme Court rejects Novartis's Glivec patent plea

In another blow to big pharma, India's Supreme Court rejects Novartis's Glivec patent plea

India’s Supreme Court has issued its eagerly anticipated judgment in the long-running Glivec patent case. Upholding previous decisions, the court ruled that the country’s patent office was right to refuse a patent to Novartis for its anti-cancer…

Unlock unlimited access to all IAM content